Health Resources and Services Administration: HIV Care Grant Program, Part B
Page 2f) health insurance premium and cost sharing assistance
g) home health care
h) medical nutrition therapy
i) hospice services
j) home and community-based health services
k) mental health services and medical case management
l) treatment adherence services
m) and substance abuse outpatient care.
The HRSA has an anticipated allocated budget amounting to $1.2 billion for Part B of the HIV Care Grant Program.
To know more about this program, kindly visit Topgovernmentgrants.com or the Grants.gov website.
The following states and territories will be deemed eligible to apply for the HIV Care Grant Program Part B:
a) all 50 states of the USA
b) the District of Columbia
c) the Commonwealth of Puerto Rico
d) the Commonwealth of the Virgin Islands
e) Guam
f) American Samoa
g) the Commonwealth of the Northern Mariana Island
h) the Republic of Palau
i) the Federated States of Micronesia
j) and the Republic of the Marshall Island
The Department of Health and Human Services, the main agency funding the HIV Care Grant Program, is the federal government's leading agency responsible for protecting the health and wellness of every American and providing all essential human services to all, especially to those are least able to help themselves.
Health Resources and Services Administration: HIV Care Grant Program, Part B
Back to Page 1
About The Author
Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs.
He also maintains Websites providing resources on environmental grants and grants for youth programs.
|
Additional Government Grants Resources
Higher Education Challenge Grants ProgramThe National Institute of Food and Agriculture has recently constituted the Higher Education Challenge Grants Program in an attempt to boost and enhance the quality of formal, postsecondary-level agricultural sciences education.
Democracy, Human Rights, Rule of Law, and Freedom of Expression and the Press for Europe and EurasiaThe Bureau of Democracy, Human Rights and Labor Affairs has recently established a funding opportunity entitled Democracy, Human Rights, Rule of Law, and Freedom of Expression/Press for Europe/Eurasia, wherein they are seeking applications and proposals that aim to develop projects promoting democracy, human rights, rule of law, and freedom of expression/press in Europe and Eurasia.
Mobile Health Tools to Promote Effective Patient Provider Communication to Underserved PopulationsThe National Institute of Nursing Research, in cooperation with the Office of Dietary Supplements has constituted the funding opportunity for Mobile Health tools aimed at the improvement of effective patient-provider communication, adherence to treatment and self-management of chronic diseases in underserved populations.
Government Grants for Housing AssistanceDo you have a bad credit record but want to get a house? the government just might help. Read this!...
Leadership Group for a Clinical Research Network on Antibacterial Resistance ProgramIn line with this mission, the National Institutes of Health has collaborated with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the Leadership Group for a Clinical Research Network on Antibacterial Resistance Program.
Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions ProgramThe Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.
Development of Therapeutics and Diagnostics for Biodefense ProgramThe National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.